NYSE$AMN

AMN Healthcare Services Inc. · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Briefing

AMN Healthcare's Q2 2023 financial results were announced, with revenue of $991 million and adjusted EPS of $2.38.

AMN Healthcare reported Q2 2023 consolidated revenue of $991.3 million, a 31% decrease from the prior year and 12% lower than the prior quarter. GAAP EPS was $1.55, and adjusted EPS was $2.38. The company is focused on technology enablement and strategic talent solutions.

  • Consolidated revenue for the quarter was $991.3 million, a 31% decrease from prior year.
  • Net income was $61 million, or $1.55 per diluted share.
  • Adjusted diluted EPS in the second quarter was $2.38.
  • The company spent $425 million year to date to repurchase 4.1 million shares of common stock.

Headline financials

Total Revenue

$991M

Previous: $1.43B-30.5%
EPS (adj)

$2.38

Previous: $3.31-28.1%
Capital Expenditures

-$43.9M

Previous: -$30.8M-42.6%
Free Cash Flow

$17M

Previous: $93M-81.8%
Net Income

$60.9M

Previous: $124M-50.8%
Operating Income

$91.7M

Previous: $184M-50.1%
Gross Profit

$330M

Previous: $460M-28.2%
Cash & Equivalents

$7.01M

Previous: $79.4M-91.2%
Total Assets

$2.64B

Previous: $3.01B-12.1%
Stock-Based Comp

$4.82M

Previous: $8.51M-43.4%

Revenue & EPS history

AMN Healthcare · Revenue · Quarterly

$991M

Q2 2023-30.5%vs Q2 2022
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Revenue by segment

AMN Healthcare · $991M total across 3 segments · Q2 2023

  • Nurse & Allied Solutions
    $689M-37.4%
  • Physician & Leadership
    $176M+0.0%
  • Technology & Workforce
    $126M-15.4%

Forward guidance

Revenue in the third quarter of 2023 is expected to be 24-26% lower than prior year and 13-15% lower sequentially.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

-0.0%

Avg return

Earnings day

-1.9%

Avg return

5 days after

-0.6%

Avg return

30 days after

52%

34 / 66 earnings

Positive

+29.2%

Q1 2026

Best reaction

-29.5%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+29.2%+38.5%+41.5%
Q4 2025+11.4%+15.8%+4.2%
Q3 2025-3.4%-10.0%-11.8%
Q2 2025+2.3%+10.2%+23.2%
Q1 2025+8.2%+7.1%+3.8%
Q4 2024+6.7%+0.5%-6.8%
Q3 2024-29.5%-36.7%-36.2%
Q2 2024-3.1%-11.9%-24.0%
Q1 2024-9.3%+3.4%-10.1%
Q4 2023-20.9%-25.5%-24.7%
Q3 2023-12.2%-17.7%-9.5%
Q2 2023-16.4%-16.6%-18.6%
Q1 2023+7.7%+10.3%+18.0%
Q4 2022-4.0%-2.3%-13.4%
Q3 2022-7.5%-0.4%+1.7%
Q2 2022+1.8%-1.7%-12.7%
Q1 2022-8.2%-10.6%-1.3%
Q4 2021+8.8%+5.3%+10.4%
Q3 2021-8.2%-1.4%+3.7%
Q2 2021+5.4%+3.8%+15.4%
Q1 2021+7.6%+10.3%+11.0%
Q4 2020+4.1%-0.7%+1.4%
Q3 2020-5.8%-7.0%-1.9%
Q2 2020+4.8%-4.5%-1.7%
Q1 2020-9.3%-12.1%+13.0%
Q4 2019+9.6%+5.6%+4.0%
Q3 2019-0.5%+2.1%+0.8%
Q2 2019+7.7%+11.4%+15.5%
Q1 2019+1.9%-0.4%-6.0%
Q4 2018-12.5%-14.7%-26.7%
Q3 2018+13.3%+11.6%+23.9%
Q2 2018-15.2%-10.4%-5.4%
Q1 2018-21.9%-21.6%-14.6%
Q4 2017+4.8%+4.8%+10.9%
Q3 2017-3.6%-1.6%+16.3%
Q2 2017+1.1%+6.9%+4.4%
Q1 2017-6.8%-6.2%-9.0%
Q4 2016+4.0%+7.9%+10.3%
Q3 2016-1.6%-2.7%-7.8%
Q2 2016-11.9%-13.8%-13.5%
Q1 2016+1.0%
Q4 2015+1.8%
Q3 2015+5.9%
Q2 2015+0.1%
Q1 2015-1.4%
Q4 2014+2.0%
Q3 2014-1.7%
Q2 2014+5.7%
Q1 2014+3.8%
Q4 2013+1.4%
Q4 2012+13.4%
Q3 2013+13.4%
Q2 2013+6.1%
Q1 2013-1.3%
Q3 2012+4.0%
Q2 2012+5.5%
Q1 2011+19.4%
Q1 2012+6.1%
Q4 2011-2.0%
Q4 2009-2.0%
Q3 2011-3.7%
Q3 2010-3.7%
Q4 2010-1.4%
Q2 2010-1.4%
Q2 2011-1.4%
Q1 2010-0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro